The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,588.00
Ask: 12,590.00
Change: -34.00 (-0.27%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: JPMorgan Raises Derwent, Cuts Shaftesbury

Fri, 15th Jan 2021 09:38

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

----------

FTSE 100

----------

UBS CUTS BT GROUP TO 'SELL' ('NEUTRAL') - TARGET 111 (116) PENCE

----------

LIBERUM RAISES WHITBREAD PRICE TARGET TO 3,000 (2,400) PENCE - 'HOLD'

----------

MORGAN STANLEY RAISES MELROSE INDUSTRIES TARGET TO 148 (140) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK CUTS COCA-COLA HBC PRICE TARGET TO 2,800 (2,850) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS DIAGEO PRICE TARGET TO 3,850 (3,900) PENCE - 'BUY'

----------

BERENBERG RAISES DIAGEO PRICE TARGET TO 3,080 (2,810) PENCE - 'HOLD'

----------

JPMORGAN RAISES SEGRO PRICE TARGET TO 910 (880) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES LAND SECURITIES PRICE TARGET TO 800 (650) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES BRITISH LAND PRICE TARGET TO 500 (430) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES BP PRICE TARGET TO 415 (400) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ROYAL DUTCH SHELL PRICE TARGET TO 1,800 (1,700) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RESUMES TESCO WITH 'OVERWEIGHT' - TARGET 300 PENCE

----------

JPMORGAN RAISES BARCLAYS PRICE TARGET TO 180 (160) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK REINITIATES ASTRAZENECA WITH 'BUY' - PRICE TARGET 10,000 PENCE

----------

DEUTSCHE BANK REINITIATES GLAXOSMITHKLINE WITH 'HOLD' - PRICE TARGET 1,400 PENCE

----------

FTSE 250

----------

JPMORGAN RAISES WORKSPACE GROUP PRICE TARGET TO 855 (820) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ST MODWEN PROPERTIES TARGET TO 445 (390) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES LONDONMETRIC PROPERTY PRICE TARGET TO 230 (220) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS HAMMERSON PRICE TARGET TO 25 (30) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES GREAT PORTLAND PRICE TARGET TO 700 (630) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS CAPITAL & COUNTIES PRICE TARGET TO 135 (150) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS UNITE GROUP TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 950 PENCE

----------

JPMORGAN CUTS SHAFTESBURY TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 550 (900) PENCE

----------

JPMORGAN RAISES DERWENT LONDON TO 'NEUTRAL' ('UNDERWEIGHT') TARGET 3,200 (2,850) PENCE

----------

CREDIT SUISSE CUTS WOOD GROUP PRICE TARGET TO 320 (350) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES WOOD GROUP PRICE TARGET TO 400 (290) PENCE - 'BUY'

----------

LIBERUM RAISES HOWDEN JOINERY GROUP PRICE TARGET TO 780 (760) PENCE - 'BUY'

----------

JPMORGAN CUTS BABCOCK INTERNATIONAL PRICE TARGET TO 270 (335) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS BABCOCK INTERNATIONAL PRICE TARGET TO 355 (430) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES IMI PRICE TARGET TO 1,400 (1,320) PENCE - 'OVERWEIGHT

----------

DEUTSCHE BANK CUTS BRITVIC PRICE TARGET TO 930 (955) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES 888 HOLDINGS PRICE TARGET TO 340 (320) PENCE - 'BUY'

----------

RBC CUTS VESUVIUS TO 'SECTOR PERFORM' ('OUTPERFORM') - TARGET 550 (480) PENCE

----------

RBC CUTS BODYCOTE TO 'SECTOR PERFORM' ('OUTPERFORM') - TARGET 770 (710) P

----------

OTHER MAIN MARKET AND AIM

----------

CREDIT SUISSE RAISES BOOHOO PRICE TARGET TO 350 (300) PENCE - 'NEUTRAL'

----------

LIBERUM RAISES BOOHOO PRICE TARGET TO 380 (350) PENCE - 'HOLD'

----------

JEFFERIES RAISES LSL PROPERTY SERVICE PRICE TARGET TO 280 (243) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS FEVERTREE DRINKS PRICE TARGET TO 2,525 (2,550) PENCE - 'HOLD'

----------

JPMORGAN RAISES HELICAL TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 485 (460) PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.